When was Akums founded?

Akums was founded in 2004 and raised its 1st funding round 15 years after it was founded.

Where is Akums located?

Akums is headquartered in Delhi, India. It is registered at Unit 101, Plot No.4, 1st Floor, Mohan Place LSC, Block-C, Saraswati Vihar, North West, Delhi, Delhi, India, 110034.

Which legal entities is Akums associated with?

Akums is associated with AKUMS DRUGS AND PHARMACEUTICALS LIMITED and 8 others.

How many employees does Akums have?

As of Mar 31, 2026, Akums has 6455 employees, reflecting a 172% year-over-year growth in headcount.

Is Akums a funded company?

Akums is a funded company, having raised a total of $***** in its 1st and only funding round, a PE round on Nov 13, 2019.

When was the latest funding round of Akums?

Akums' latest funding was a $***** PE round on Nov 13, 2019, with participation from 1 investor. Its primary sector is Biopharma Outsourcing. In India, the Biopharma Outsourcing sector has seen $349M in funding in 2026 to date.

What is the annual revenue of Akums?

Annual revenue of Akums is more than ₹1,000 Cr as on Mar 31, 2026

Where does Akums rank among its competitors?

Akums ranks 3rd amongst 465 active competitors, of which 30 are funded. It stands 3rd in terms of total funding among its competitors. The most recent competitor to raise funding was Scimplify, which secured $25M in Jul, 2026.

Who are the top competitors of Akums?

Akums' top competitors include Patheon, Scimplify and EirGenix. Among them, Scimplify secured the most recent funding round in July, 2026.

Akums - 2026 Company Profile, Team, Funding, Competitors & Financials

Company Details

Pharmaceutical contract development and manufacturing organization providing API, formulation, nutraceutical, and cosmetic production services. The firm produces active pharmaceutical ingredients, formulates finished dosage forms, and manufactures tablets, capsules, liquids, and injectables. It provides end‑to‑end manufacturing solutions for clients in the pharmaceutical and healthcare sectors.

Website: www.akums.in/
Social
Email ID: *****@akums.net
Phone Number: +91 **********
Registered Address: Unit 101, Plot No.4, 1st Floor, Mohan Place LSC, Block-C, Saraswati Vihar, North West, Delhi, Delhi, India, 110034

Key Metrics

Founded Year

2004

Location

Delhi, India

Stage

Public

Total Funding

$44.4M in 1 round

Latest Funding Round

PE, Nov 13, 2019, $*****

Investors

Quadria Capital

Ranked

3^rd among 465 active competitors

Annual Revenue

₹1,000+ Cr as on Mar 31, 2026

Employee Count

6,455 as on Mar 31, 2026

Investment & Acquisitions

Ankur Drugs & 5 more

Similar Companies

Patheon & 336 more

Exit Details

Public

View Akums' full profile

Akums is associated with 9 legal entities given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count
MEDIBOX PHARMA PRIVATE LIMITED CIN: U72900DL2016PTC399490 , India, Active	Aug 19, 2016	₹10 - ₹50 Cr (As on Mar 31, 2026)	3 (As on Apr 30, 2026)
AVHA LIFESCIENCES PRIVATE LIMITED CIN: U51909DL2017PTC325425 , India, Active	Oct 30, 2017	0 - ₹10 Cr (As on Mar 31, 2026)	1 (As on Mar 01, 2022)
AKUMS FOUNDATION CIN: U85300DL2019NPL355543 , India, Active	Sep 25, 2019	0 - ₹10 Cr (As on Mar 31, 2026)	-
MAXCURE NUTRAVEDICS LIMITED CIN: U74899DL1994PLC057323 , India, Active	Feb 10, 1994	₹500 - ₹1,000 Cr (As on Mar 31, 2026)	229 (As on May 01, 2026)
AKUMS HEALTHCARE LIMITED CIN: U24304DL2020PLC375098 , India, Active	Dec 29, 2020	₹50 - ₹100 Cr (As on Mar 31, 2026)	260 (As on May 31, 2026)
AKOME LIFECARE PRIVATE LIMITED CIN: U24100DL2022PTC393711 , India, Active	Feb 11, 2022	₹10 - ₹50 Cr (As on Mar 31, 2025)	11 (As on May 31, 2026)
MALIK LIFESCIENCES PRIVATE LIMITED CIN: U63021DL2004PTC299408 , India, Active	Feb 05, 2004	₹500 - ₹1,000 Cr (As on Mar 31, 2026)	416 (As on May 31, 2026)
AKUMS LIFESCIENCES LIMITED CIN: U24231CH1996PLC017755 , India, Amalgamated	Feb 22, 1996	₹100 - ₹500 Cr (As on Mar 31, 2023)	-
AKUMS DRUGS AND PHARMACEUTICALS LIMITED CIN: L24239DL2004PLC125888 , India, Active	Apr 19, 2004	₹1,000+ Cr (As on Mar 31, 2026)	1707 (As on May 01, 2026)

Akums got listed on Aug 06, 2024.

Click here to take a look at Akums's IPO in detail

Akums has raised a total funding of $44.4M over 1 round. Its latest funding round was a PE round on Nov 13, 2019 for $*****. 1 investor participated in its latest round. Akums has 1 institutional investor.

Here is the list of recent funding rounds of Akums:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Nov 13, 2019	1116399	PE	3468484	1019259	4026431	6094502

Access funding benchmarks and valuations. Sign up today!

View details of Akums's funding rounds and investors

The founders of Akums are Sandeep Jain and Sanjeev Jain.

Here are the details of Akums' key team members:

Sandeep Jain: Co-Founder & MD of Akums and founder of 1 other company. They are also an angel investor in 11 startups and serve on the board of 1 company.
Contact Info: 1 email address
Sanjeev Jain: Co-Founder & Director of Akums. They are also an angel investor in 2 startups and serve on the boards of 3 companies.
Contact Info: 1 phone number

Akums' Board of Directors

Akums's board has 7 active members. Sunil Kumar Thakur and Sandeep Jain are part of team and Sanjay Sinha, Anilkumar Arvindlal Amin, Kewal Kundanlal Handa, Matangi Gowrishankar and Satwinder Singh are independent board members.

Here is the list of Akums' board of directors:

Name	Type	Representing	Status	Duration
Sandeep Jain	Team	-	Current	22y 6m
txnbuzw	Team	-	Past	8y 4m
Sunil Kumar Thakur	Investor	-	Current	2y 9m
Sanjay Sinha	Independent board member	-	Current	2y 9m
yavczvs	Independent board member	-	Current	5y 9m
fensfwl	Independent board member	-	Current	8y 5m
xeonebm	Independent board member	-	Current	3y 4m
oeyvqnr	Independent board member	-	Current	3y 3m

View details of Akums's Founder profiles and Board Members

Akums' employee count trend

Akums has 6,455 employees as of Mar 26. Here is Akums's employee count trend over the years:

Uncover Akums' growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Akums include Patheon, Scimplify and EirGenix. Here is the list of Top 10 competitors of Akums, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Patheon 1974, Durham (United States), Acquired	Global CDMO providing integrated drug development, clinical trials, and manufacturing services	$141M	Frazier Healthcare Partners, Audax Group & 3 others	75/100
2nd	Scimplify 2023, Bengaluru (India), Series B	Manufacturer of specialty chemicals	$79.2M	3one4 Capital, Bertelsmann India Investments ... & 23 others	71/100
3rd	Akums 2004, Delhi (India), Public	Pharmaceutical contract development and manufacturing organization providing API, formulation, nutraceutical, and cosmetic production services	$44.4M	Quadria Capital	65/100
4th	EirGenix 2012, Taipei (Taiwan), Public	Contract development and manufacturing organization for biologics	-	CDIB Capital Group, Taiwania Capital & 3 others	60/100
5th	SAI Parenterals 2001, Hyderabad (India), Public	Provider of parenteral products and pharmaceutical services	$5.83M	Samarsh Capital, Blue Lotus Capital & 3 others	60/100
6th	KBI Biopharma 1996, Durham (United States), Acquired	Provider of protein formulation, process & cell line development, and cGMP services	$21M	Ballast Point Ventures, NCBiotech & 1 others	59/100
7th	Upperton 1999, Nottingham (United Kingdom), Acquired	Spray drying and drug formulation services	-	Inflexion, Europa	57/100
8th	Daewoong Pharmaceutical 1945, Seoul (South Korea), Public	Developer of therapies for treating gastrointestinal disorders	-	Business Innovation Network	57/100
9th	Insud Pharma 1977, Madrid (Spain), Funding Raised	Developer and manufacturer of finished formulations, APIs and monoclonal antibodies	-	Gates	56/100
10th	Kemwell Biopharma 1980, Bengaluru (India), Acquired	A biologics CDMO providing integrated development and manufacturing	$5.72M	Subhashfamilytrust & 4 others	56/100

Get insights and benchmarks for competitors of 2M+ companies! Sign up today!

Looking for more details on Akums's competitors? Click here to see the top ones

AKUMS DRUGS AND PHARMACEUTICALS LIMITED, the legal entity associated with Akums, generated more than ₹1,000 Cr in revenue for the financial year ending on Mar 31, 2026. The revenue of AKUMS DRUGS AND PHARMACEUTICALS LIMITED has a compounded annual growth rate (CAGR) of 8% in the last 1 year.

Financial Statement Summary

Metrics	FY 2025-26	FY 2024-25	FY 2023-24	FY 2022-23	FY 2021-22
Income Statement
Revenue	8405	2780	9328	9010	2783
Total Sales	2496	2333	1338	7198	2258
Total Expenses	1407	9804	3641	3260	1694
Operating Expenses	4225	6708	7806	5757	7310
Employee Expenses	8268	3419	5184	8744	9434
Marketing Expenses	9364	7993	2756	8764	8424
Operating Income (EBIT)	4231	7078	3977	5360	5698
Interest Expenses	4731	4858	7772	6909	5812
Expenses from other activities	3391	1848	1841	6983	7626
EBITDA	2796	3494	7846	3941	8868
Taxes	8467	4746	8212	5979	5290
Net Profit	7777	2988	7591	4072	9658
Balance Sheet
Assets	8515	7437	1614	9645	9482
Cash Equivalent	9249	4870	2665	7009	4630
Accounts Receivables	3258	9358	1846	5068	8875
Inventory	7471	7568	9684	2080	7897
Liabilities	5834	1022	6600	3053	1127
Total Debt	2955	1401	5118	9106	1395
Accounts Payable	7699	9004	7836	4675	1629
Equities	6272	4175	1300	5614	9279
Cashflow Statement
Cash from Operating activities	7600	2061	8801	1939	7504
Cash from Investing activities	3366	4231	5581	1293	1890
Net cash from Financing activities	7808	4315	2936	2181	7420

Detailed Financials (Income Statement, Balance Sheet, Cashflow Statement)

Founders (largest shareholder) own 90.33%, Funds own 9.66%, Enterprises own 0.00% and Other People own 0.01%. The net worth of Akums's founders is INR 2,990Cr as of Nov 13, 2019. The cap table displayed below is for AKUMS DRUGS AND PHARMACEUTICALS LIMITED which is the legal entity associated with Akums.

Shareholders Name	Post Round Holding %	Net worth	Cumulative Investment	Realised Returns	Unrealised Returns	Return Multiple
Founder	90.33%	2,990Cr	4902437	8443492	8994936	2419921
Sandeep Jain	4549875	7364470	1700222	3072210	2476419	6644803
Sanjeev Jain	9138608	1362629	3528921	8571631	9636010	7144450
Fund	9.66%	320Cr	7202430	6907896	3339266	6509701
Quadria Capital	4743899	9129715	9480760	9024452	8144075	9217336
Enterprise	-	0	0	0	0	0
Other People	0.01%	31.9L	0	0	0	0
Total	100.00%	3,310Cr	7188301	5996215	7635074	7180520

Notes: The column Net Worth represents the net worth of investments made by that entity, as per the latest cap table.

Disclaimer

Akums has made 3 investments in companies including Medibox and Medibox. Akums has also acquired 3 companies including Ankur Drugs and Parabolic Drugs.

Here is the list of investments & acquisitions:

Date of Investment/Acquisition	Type	Company Name	Founded Year	Location
Apr 26, 2022	Acquisition	Ankur Drugs	1997	Mumbai (India)
Sep 14, 2019	Investments	Medibox	2016	Bengaluru (India)
Apr 2019	Acquisition	Parabolic Drugs	1996	Chandigarh (India)